Niacin for reduction of cardiovascular risk.
作者信息
Hu Miao, Tomlinson Brian
出版信息
N Engl J Med. 2014 Nov 13;371(20):1941-2. doi: 10.1056/NEJMc1411240.
PMID:25390751
Abstract
摘要
相似文献
1
Niacin for reduction of cardiovascular risk.烟酸用于降低心血管风险。
N Engl J Med. 2014 Nov 13;371(20):1941-2. doi: 10.1056/NEJMc1411240.
2
Niacin for reduction of cardiovascular risk.
N Engl J Med. 2014 Nov 13;371(20):1940-1. doi: 10.1056/NEJMc1411240.
3
Niacin for reduction of cardiovascular risk.
N Engl J Med. 2014 Nov 13;371(20):1943. doi: 10.1056/NEJMc1411240.
4
Niacin for reduction of cardiovascular risk.
N Engl J Med. 2014 Nov 13;371(20):1943. doi: 10.1056/NEJMc1411240.
5
Niacin for reduction of cardiovascular risk.
N Engl J Med. 2014 Nov 13;371(20):1941. doi: 10.1056/NEJMc1411240.
6
Niacin for reduction of cardiovascular risk.
N Engl J Med. 2014 Nov 13;371(20):1942. doi: 10.1056/NEJMc1411240.
7
Niacin and HDL cholesterol--time to face facts.烟酸与高密度脂蛋白胆固醇——是时候面对现实了。
N Engl J Med. 2014 Jul 17;371(3):271-3. doi: 10.1056/NEJMe1406410.
8
ACP Journal Club: adding niacin plus laropiprant to statins did not reduce vascular events and increased serious adverse events.
Ann Intern Med. 2014 Nov 18;161(10):JC8. doi: 10.7326/0003-4819-161-10-201411180-02008.
9
Niacin for reduction of cardiovascular risk.烟酸用于降低心血管风险。
N Engl J Med. 2014 Nov 13;371(20):1943-4. doi: 10.1056/NEJMc1411240.
10
Dyslipidaemia: Niacin-laropiprant fails to reduce the risk of vascular events.
Nat Rev Cardiol. 2014 Oct;11(10):558. doi: 10.1038/nrcardio.2014.116. Epub 2014 Aug 5.
引用本文的文献
1
Effects of phenotypic and genotypic factors on the lipid responses to niacin in Chinese patients with dyslipidemia.表型和基因型因素对中国血脂异常患者烟酸脂质反应的影响。
Medicine (Baltimore). 2015 May;94(20):e881. doi: 10.1097/MD.0000000000000881.
Zotero 插件